Results 161 to 170 of about 140,776 (178)

Dimethyl fumarate treatment restrains the antioxidative capacity of T cells to control autoimmunity

Brain, 2021
Luisa Klotz, Nicholas Schwab, Martin Diebold   +2 more
exaly  

Expanding spectrum of opportunistic infections associated with dimethyl fumarate

Multiple Sclerosis Journal, 2021
David Croteau, Paul R Lee, Allen Brinker
exaly  

A comparative study of teriflunomide and dimethyl fumarate within the Swedish MS Registry

Multiple Sclerosis Journal, 2022
Tim Spelman, Jan Hillert
exaly  

Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapy

Therapeutic Advances in Chronic Disease, 2016
Ralf Linker
exaly  

Evidence of activation of the Nrf2 pathway in multiple sclerosis patients treated with delayed-release dimethyl fumarate in the Phase 3 DEFINE and CONFIRM studies

Multiple Sclerosis Journal, 2017
Robert J. Fox, Ralf Gold, Katherine T Dawson   +2 more
exaly  

Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS

Multiple Sclerosis Journal, 2018
Timo Uphaus, Amit Bar-or, Frauke Zipp
exaly  

Factors associated with dimethyl fumarate-induced lymphopenia

Journal of the Neurological Sciences, 2019
Susana Sainz de la Maza, Noelia Villarrubia, Lucienne Costa-Frossard França   +2 more
exaly  

Dimethyl Fumarate for Treatment of Multiple Sclerosis: Mechanism of Action, Effectiveness, and Side Effects

Current Neurology and Neuroscience Reports, 2013
Ralf Linker, Ralf Gold
exaly  

Dimethyl fumarate treatment alters NK cell function in multiple sclerosis

European Journal of Immunology, 2018
Peter Calabresi, Pavan Bhargava
exaly